TuHURA BIOSCIENCES, INC./NV Interest Expense on Debt
TuHURA BIOSCIENCES, INC./NV (HURA) reported Interest Expense on Debt of $467.63 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV interest expense, debt for the quarter ending 2026-06-30 was $467.63K.
- TuHURA BIOSCIENCES, INC./NV interest expense, debt for the quarter ending 2025-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV interest expense, debt for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV interest expense, debt for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV interest expense, debt for fiscal 2015 was $2.09K, a 74.31% decline from fiscal 2014.
- TuHURA BIOSCIENCES, INC./NV interest expense, debt for fiscal 2014 was $8.14K.
- TuHURA BIOSCIENCES, INC./NV interest expense, debt for fiscal 2013 was $8.02K, a 6.63% increase from fiscal 2012.
- TuHURA BIOSCIENCES, INC./NV interest expense, debt for fiscal 2012 was $7.52K, a 10.10% increase from fiscal 2011.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month | Interest Expense, Debt 14 month | Interest Expense, Debt 36 month | Interest Expense, Debt 42 month | Interest Expense, Debt 45 month | Interest Expense, Debt 48 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $467.63K 10-Q · filed 2026-08-14 | $467.63K 10-Q · filed 2026-08-14 | |||||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | |||||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $0.00 derived: sum of 2 quarters · filed 2016-09-13 | $0.00 derived: sum of 3 quarters · filed 2016-09-13 | $2.09K 10-K · filed 2016-09-13 | |||||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-05-12 | $2.09K 10-Q · filed 2016-05-12 | $4.14K derived: sum of 4 quarters · filed 2016-05-12 | |||||
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | $2.09K 10-Q · filed 2016-02-12 | $4.14K derived: sum of 3 quarters · filed 2016-02-12 | $6.16K derived: sum of 4 quarters · filed 2016-02-12 | |||||
| 2014-09-30 | $2.09K 10-Q · filed 2015-11-16 | $4.14K derived: sum of 2 quarters · filed 2015-11-16 | $6.16K derived: sum of 3 quarters · filed 2015-11-16 | $8.20K derived: sum of 4 quarters · filed 2015-11-16 | |||||
| 2014-06-30 | $2.05K derived: 10-K 6 month − 10-Q 3 month · filed 2014-08-28 | $4.07K 10-K · filed 2014-08-28 | $6.11K derived: sum of 3 quarters · filed 2015-02-12 | $8.14K 10-K · filed 2015-11-16 | |||||
| 2014-03-31 | $2.02K 10-Q · filed 2014-05-15 | $4.06K derived: sum of 2 quarters · filed 2015-02-12 | $6.09K 10-Q · filed 2015-05-15 | $8.08K derived: sum of 4 quarters · filed 2015-02-12 | $24.39K 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | $2.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-12 | $4.07K 10-Q · filed 2015-02-12 | $6.07K derived: sum of 3 quarters · filed 2015-02-12 | $8.02K 10-K · filed 2014-08-28 | $22.37K 10-K · filed 2014-03-10 | ||||
| 2013-09-30 | $2.03K 10-Q · filed 2014-11-07 | $4.02K derived: sum of 2 quarters · filed 2014-11-07 | $5.98K 10-Q · filed 2013-11-08 | $7.87K derived: sum of 4 quarters · filed 2014-11-07 | $20.33K 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $1.99K derived: 10-K 6 month − 10-Q 3 month · filed 2014-08-28 | $3.95K 10-K · filed 2014-08-28 | $5.84K derived: sum of 3 quarters · filed 2014-08-28 | $7.73K derived: sum of 4 quarters · filed 2014-08-28 | $18.30K 10-Q · filed 2013-08-12 | ||||
| 2013-03-31 | $1.96K 10-Q · filed 2014-05-15 | $3.85K derived: sum of 2 quarters · filed 2014-08-28 | $5.74K derived: sum of 3 quarters · filed 2014-08-28 | $7.61K derived: sum of 4 quarters · filed 2014-08-28 | $16.31K 10-Q · filed 2013-05-15 | ||||
| 2012-12-31 | $1.89K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-28 | $3.78K derived: sum of 2 quarters · filed 2014-08-28 | $5.66K derived: sum of 3 quarters · filed 2014-08-28 | $7.52K 10-K · filed 2014-08-28 | |||||
| 2012-09-30 | $1.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $3.77K derived: sum of 2 quarters · filed 2013-11-08 | $5.63K 10-Q · filed 2013-11-08 | ||||||
| 2012-06-30 | $1.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $3.74K 10-Q · filed 2013-08-12 | |||||||
| 2012-03-31 | $1.86K 10-Q · filed 2013-05-15 | ||||||||
| 2011-12-31 | $6.83K 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |